tiprankstipranks
Trending News
More News >
Panacea Biotec Limited (IN:PANACEABIO)
:PANACEABIO
India Market

Panacea Biotec Limited (PANACEABIO) Ratios

Compare
0 Followers

Panacea Biotec Limited Ratios

IN:PANACEABIO's free cash flow for Q3 2025 was ₹0.62. For the 2025 fiscal year, IN:PANACEABIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.03. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
0.54 1.57 1.57 1.71 1.30
Quick Ratio
0.45 0.99 0.99 1.10 1.03
Cash Ratio
0.02 0.15 0.15 0.12 0.06
Solvency Ratio
0.09 0.09 0.09 0.01 1.20
Operating Cash Flow Ratio
0.11 >-0.01 >-0.01 -1.28 -0.14
Short-Term Operating Cash Flow Coverage
0.17 0.00 0.00 -7.70K -2.09K
Net Current Asset Value
₹ 1.37B₹ 827.31M₹ 827.31M₹ 1.37B₹ 1.04B
Leverage Ratios
Debt-to-Assets Ratio
0.47 0.02 0.02 0.02 0.02
Debt-to-Equity Ratio
1.85 0.02 0.02 0.02 0.04
Debt-to-Capital Ratio
0.65 0.02 0.02 0.02 0.04
Long-Term Debt-to-Capital Ratio
0.12 0.02 0.02 0.02 0.04
Financial Leverage Ratio
3.93 1.47 1.47 1.51 2.10
Debt Service Coverage Ratio
0.29 10.77 10.77 2.18 7.24
Interest Coverage Ratio
-1.30 -12.35 -12.35 -23.14 -0.27
Debt to Market Cap
0.54 0.03 0.03 0.03 0.04
Interest Debt Per Share
119.42 3.99 3.99 4.03 34.94
Net Debt to EBITDA
-0.35 -0.63 -0.63 -0.35 >-0.01
Profitability Margins
Gross Profit Margin
55.19%58.85%51.90%45.07%54.49%
EBIT Margin
33.92%0.74%0.74%3.75%247.14%
EBITDA Margin
45.86%7.43%7.43%12.25%253.93%
Operating Profit Margin
-24.44%-7.91%-7.91%-22.34%-7.34%
Pretax Profit Margin
10.75%0.26%0.26%2.78%219.78%
Net Profit Margin
8.34%-0.21%-0.21%-7.34%163.57%
Continuous Operations Profit Margin
9.04%-0.27%-0.27%-7.34%163.58%
Net Income Per EBT
77.60%-79.42%-79.42%-263.67%74.43%
EBT Per EBIT
-43.98%-3.34%-3.34%-12.46%-2992.29%
Return on Assets (ROA)
-2.66%-0.09%-0.09%-2.66%60.49%
Return on Equity (ROE)
-4.00%-0.14%-0.14%-4.00%127.04%
Return on Capital Employed (ROCE)
-10.94%-4.75%-4.75%-10.94%-4.94%
Return on Invested Capital (ROIC)
28.84%4.84%4.84%28.84%-3.68%
Return on Tangible Assets
-2.71%-0.10%-0.10%-2.71%60.97%
Earnings Yield
-5.08%-0.14%-0.14%-5.08%118.79%
Efficiency Ratios
Receivables Turnover
4.13 9.07 9.74 7.65 8.07
Payables Turnover
0.75 1.50 1.75 1.42 1.28
Inventory Turnover
2.49 1.29 1.51 1.25 1.41
Fixed Asset Turnover
0.56 0.88 0.88 0.75 1.11
Asset Turnover
0.33 0.45 0.45 0.36 0.37
Working Capital Turnover Ratio
-1.61 2.71 2.71 1.94 4.08
Cash Conversion Cycle
83.47 78.71 70.39 83.47 18.45
Days of Sales Outstanding
47.69 40.25 37.48 47.69 45.21
Days of Inventory Outstanding
291.95 282.22 241.48 291.95 258.81
Days of Payables Outstanding
256.17 243.76 208.57 256.17 285.57
Operating Cycle
339.63 322.47 278.96 339.63 304.02
Cash Flow Ratios
Operating Cash Flow Per Share
17.12 -0.02 -0.02 -69.14 -17.70
Free Cash Flow Per Share
16.34 -12.64 -12.64 -75.82 -19.75
CapEx Per Share
0.78 12.62 12.62 6.69 2.04
Free Cash Flow to Operating Cash Flow
0.95 778.18 778.18 1.10 1.12
Dividend Paid and CapEx Coverage Ratio
21.93 >-0.01 >-0.01 -10.34 -8.67
Capital Expenditure Coverage Ratio
21.93 >-0.01 >-0.01 -10.34 -8.67
Operating Cash Flow Coverage Ratio
0.16 >-0.01 >-0.01 -20.94 -3.17
Operating Cash Flow to Sales Ratio
0.23 >-0.01 >-0.01 -0.92 -0.16
Free Cash Flow Yield
-69.91%-9.56%-9.56%-69.91%-13.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
31.76 -694.27 -694.27 -19.68 0.84
Price-to-Sales (P/S) Ratio
2.65 1.46 1.46 1.44 1.38
Price-to-Book (P/B) Ratio
3.42 0.97 0.97 0.79 1.07
Price-to-Free Cash Flow (P/FCF) Ratio
11.97 -10.47 -10.47 -1.43 -7.51
Price-to-Operating Cash Flow Ratio
11.43 -8.14K -8.14K -1.57 -8.37
Price-to-Earnings Growth (PEG) Ratio
-0.21 7.19 7.19 0.19 >-0.01
Price-to-Fair Value
3.42 0.97 0.97 0.79 1.07
Enterprise Value Multiple
8.82 18.98 18.98 11.44 0.53
Enterprise Value
6.45B 7.88B 7.88B 6.45B 8.92B
EV to EBITDA
11.44 18.98 18.98 11.44 0.53
EV to Sales
1.40 1.41 1.41 1.40 1.35
EV to Free Cash Flow
-1.39 -10.13 -10.13 -1.39 -7.37
EV to Operating Cash Flow
-1.52 -7.88K -7.88K -1.52 -8.22
Tangible Book Value Per Share
54.01 130.28 130.28 132.92 135.83
Shareholders’ Equity Per Share
57.21 136.74 136.74 137.73 138.58
Tax and Other Ratios
Effective Tax Rate
0.16 2.02 2.02 3.64 0.26
Revenue Per Share
73.85 90.81 90.81 75.09 107.63
Net Income Per Share
6.16 -0.19 -0.19 -5.51 176.05
Tax Burden
-2.64 -0.79 -0.79 -2.64 0.74
Interest Burden
0.74 0.36 0.36 0.74 0.89
Research & Development to Revenue
0.07 0.00 0.00 0.07 0.05
SG&A to Revenue
0.03 0.05 0.05 0.03 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-33.08 0.09 0.09 -33.08 -0.07
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis